Villar LM, Lampe E, de Almeida AJ, Scalioni LP, Lewis-Ximenez LL, Custódio MJ, Del Campo JA, Ranchal I, Villela-Nogueira CA, Romero-Gomez M

Idioma: Ingles.
Referencias bibliográficas: 7
Paginas: 139-140
Archivo PDF: 100.74 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. El Husseiny NM, Fahmy HM, Mohamed WA, Amin HH. Relationship between vitamin D and IL-23, IL-17 and macrophage chemoattractant protein-1 as markers of fibrosis in hepatitis C virus Egyptians. World J Hepatol 2012; 4: 242-7.

2. Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, Vermehren J, Herrmann E, et al. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J Hepatol 2011; 54: 887-93.

3. Falleti E, Cmet S, Fabris C, Fattovich G, Cussigh A, Bitetto D, Ceriani E, et al. Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C. PLoS One 2013; 8(11): e80764.

4. Villar LM, Del Campo JA, Ranchal I, Lampe E, Romero-Gomez M. Association between vitamin D and hepatitis C virus infection: a meta-analysis. World J Gastroenterol 2013; 19: 5917-24.

5. Rahman AH, Branch AD. Vitamin D for your patients with chronic hepatitis C? J Hepatol 2013; 58: 184-9.

6. Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A, Bignulin S, et al. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int 2011; 24: 43-50.

7. Kitson MT, Sarrazin C, Toniutto P, Eslick GD, Roberts SK. Vitamin D level and sustained virologic response to interferonbased antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis. J Hepatol 2014; 61: 1247-52.